Ani Pharmaceuticals (ANIP) Total Debt Growth (3y) (2015 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Total Debt Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | -7.08% |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | -10.47% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 74.38% |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | -0.36% |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 0.96% |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | -0.95% |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 6.89% |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.95% |
| Mar 31, 2026 | -0.32% |
| Dec 31, 2025 | 2.56% |
| Sep 30, 2025 | 2.96% |
| Jun 30, 2025 | 3.13% |
| Mar 31, 2025 | 3.29% |
| Dec 31, 2024 | 3.46% |
| Sep 30, 2024 | 16.58% |
| Jun 30, 2024 | 11.69% |
| Mar 31, 2024 | 15.89% |
| Dec 31, 2023 | 16.96% |
| Sep 30, 2023 | 18.02% |
| Jun 30, 2023 | 17.72% |
| Mar 31, 2023 | 15.51% |
| Dec 31, 2022 | 15.54% |
| Sep 30, 2022 | 60.75% |
| Jun 30, 2022 | 60.17% |
| Mar 31, 2022 | 16.71% |
| Dec 31, 2021 | 59.70% |
| Sep 30, 2021 | 13.05% |